share_log

Navidea Biopharmaceuticals Received Written Notification That NYSE Is Determined To Commence Proceedings To Delist The Company's Stock; The Company's Board Will Appeal The Determination To Commence Delisting Proceedings

Navidea Biopharmaceuticals Received Written Notification That NYSE Is Determined To Commence Proceedings To Delist The Company's Stock; The Company's Board Will Appeal The Determination To Commence Delisting Proceedings

Navidea Biopharmaceuticals收到书面通知,称纽约证券交易所决心启动公司股票退市程序;公司董事会将对启动退市程序的决定提出上诉
Benzinga ·  2023/07/31 01:07

Navidea Biopharmaceuticals Received Written Notification That NYSE Is Determined To Commence Proceedings To Delist The Company's Stock; The Company's Board Will Appeal The Determination To Commence Delisting Proceedings

Navidea Biopharmaceuticals收到书面通知,称纽约证券交易所决心启动公司股票退市程序;公司董事会将对启动退市程序的决定提出上诉

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发